MedTrace Logo

New-DES vs BMS in SVG -1 Year Outcomes

NCT04338308 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 792

Last updated 2020-04-08

No results posted yet for this study

Summary

Data regarding the efficacy of the percutaneous coronary intervention (PCI) with new-designed drug-eluting stent (new-DES) vs. bare metal stent (BMS) of saphenous vein grafts (SVG) stenosis is scarce. The primary objective was to compare one-year clinical outcomes of PCI in stenosis of SVG using new-DES vs. BMS in a real-world population. We carried out a multi-center registry comparing new-DES with BMS in all consecutive patients undergoing PCI of SVG. The primary composite endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 1 year.

Conditions

Interventions

DEVICE

new-DES

with ot without embolic protection device

DEVICE

BMS

with ot without embolic protection device

Sponsors & Collaborators

  • Wojciech Wojakowski

    collaborator UNKNOWN

  • Medical University of Silesia

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-01
Primary Completion
2015-10-01
Completion
2020-03-01

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04338308 on ClinicalTrials.gov